Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate. / Picone, R; Kajtaniak, E L; Nielsen, L S; Behrendt, N; Mastronicola, M.R.; Cubellis, M.V.; Stoppelli, M P; Pedersen, S; Danø, K; Blasi, F.
I: Journal of Cell Biology, Bind 108, Nr. 2, 02.1989, s. 693-702.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate
AU - Picone, R
AU - Kajtaniak, E L
AU - Nielsen, L S
AU - Behrendt, N
AU - Mastronicola, M.R.
AU - Cubellis, M.V.
AU - Stoppelli, M P
AU - Pedersen, S
AU - Danø, K
AU - Blasi, F.
PY - 1989/2
Y1 - 1989/2
N2 - A specific surface receptor for urokinase plasminogen activator (uPA) recognizes the amino-terminal growth factor-like sequence of uPA, a region independent from and not required for the catalytic activity of this enzyme. The properties of the uPA receptor (uPAR) and the localization and distribution of uPA in tumor cells and tissues suggest that the uPA/uPAR interaction may be important in regulating extracellular proteolysis-dependent processes (e.g., invasion, tissue destruction). Phorbol myristate acetate (PMA), an inducer of U937 cell differentiation to macrophage-like cells, elicits a time- and concentration-dependent increase in the number of uPAR molecules as shown by binding, cross-linking, and immunoprecipitation studies. The effect of PMA is blocked by cycloheximide. Overall, the data indicate that PMA increases the synthesis of uPA. PMA treatment also causes a decrease in the affinity of the uPAR for uPA, thus uncovering another way of regulating the interaction between uPA and uPAR. In addition, the PMA treatment causes a modification of migration of the cross-linked receptor in mono- and bidimensional gel electrophoresis.
AB - A specific surface receptor for urokinase plasminogen activator (uPA) recognizes the amino-terminal growth factor-like sequence of uPA, a region independent from and not required for the catalytic activity of this enzyme. The properties of the uPA receptor (uPAR) and the localization and distribution of uPA in tumor cells and tissues suggest that the uPA/uPAR interaction may be important in regulating extracellular proteolysis-dependent processes (e.g., invasion, tissue destruction). Phorbol myristate acetate (PMA), an inducer of U937 cell differentiation to macrophage-like cells, elicits a time- and concentration-dependent increase in the number of uPAR molecules as shown by binding, cross-linking, and immunoprecipitation studies. The effect of PMA is blocked by cycloheximide. Overall, the data indicate that PMA increases the synthesis of uPA. PMA treatment also causes a decrease in the affinity of the uPAR for uPA, thus uncovering another way of regulating the interaction between uPA and uPAR. In addition, the PMA treatment causes a modification of migration of the cross-linked receptor in mono- and bidimensional gel electrophoresis.
KW - Cell Count
KW - Cell Line
KW - Cross-Linking Reagents
KW - Electrophoresis, Polyacrylamide Gel
KW - Enzyme Precursors
KW - Humans
KW - Immunosorbent Techniques
KW - Molecular Weight
KW - Monocytes
KW - Peptide Fragments
KW - Plasminogen Activators
KW - Receptors, Cell Surface
KW - Receptors, Urokinase Plasminogen Activator
KW - Tetradecanoylphorbol Acetate
KW - Urokinase-Type Plasminogen Activator
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
M3 - Journal article
C2 - 2537321
VL - 108
SP - 693
EP - 702
JO - Journal of Cell Biology
JF - Journal of Cell Biology
SN - 0021-9525
IS - 2
ER -
ID: 180824409